GMAB
Genmab A/S Sponsored ADR · NASDAQ
34.15
+1.50 (+4.59%)
2026-09-15 20:50:30 UTC
GMAB (Genmab A/S Sponsored ADR) is trading at 34.15, up 4.59% on the session. This page shows the live price, the session range and key statistics. Data updated 2026-09-15 20:50:30 UTC.
Key statistics
Open
32.34
Day high
34.19
Day low
32.34
Volume
3.1M
52w high
35.43
52w low
23.62
Avg vol 10d
1.6M
Market cap
19.5B
P/E ratio
27.0
EPS
1.28
Company profile
Genmab A/S Sponsored ADRGenmab A/S Sponsored ADR (GMAB) operates in the biotechnology industry within the health technology sector and is domiciled in Denmark. The company reports 3,029 employees. Trailing revenue is 3.7B with net income of 965.9M. Market capitalisation stands at 19.5B.
Sector
Health Technology
Industry
Biotechnology
Country
Denmark
Employees
3,029
Market cap
19.5B
Float shares
587.1M
Beta (1y)
1.08
Next earnings
05 Nov 2026
Revenue (TTM)
3.7B
Net income (TTM)
965.9M
Gross margin
93.03%
Operating margin
32.27%
Return on equity
13.96%
Debt / equity
0.89
P/E (TTM)
27.0
EPS (TTM)
1.28
52-week high
35.43
52-week low
23.62
Avg volume (10d)
1.6M



